Analysis of Prior Aspirin Treatment on in-Hospital Outcome of Geriatric COVID-19 Infected Patients

Analysis of Prior Aspirin Treatment on in-Hospital Outcome of Geriatric COVID-19 Infected Patients

<i>Background and Objectives</i>: Aspirin (ASA) is a commonly used antithrombotic drug that has been demonstrated to reduce venous thromboembolism. The aim was to analyze if geriatric COVID-19 patients undergoing a 100 mg/day Aspirin (ASA) treatment prior to hospitalization differ in hos...

Full description

Bibliographic Details
Main Authors: Khaoula Zekri-Nechar, José Barberán, José J. Zamorano-León, María Durbán, Alcira Andrés-Castillo, Carlos Navarro-Cuellar, Antonio López-Farré, Ana López-de-Andrés, Rodrigo Jiménez-García, Carlos H. Martínez-Martínez
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Medicina
Subjects:
aspirin
COVID-19
elderly population
low molecular weight heparin
pulmonary thromboembolism
mortality
Online Access:https://www.mdpi.com/1648-9144/58/11/1649

Similar Items

Similar Items